BROWSE·page 700 of 710

Browse EX-10 agreements

8,509 total material contract exhibits.


EX-10.1

EX-10.1

X4 Pharmaceuticals, Inc. SECOND AMENDED AND RESTATED 2017 EQUITY INCENTIVE PLAN

(AS AMENDED AND RESTATED MAY 11, 2026)

1.    Purpose

The purpose of this Second Amended and Restated 2017 Equity Incentive Plan (the “Plan”) of X4 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), is to advance the interests of the Company’s stockholders by enhancing the Company’s ability to attract, retain and motivate persons who are expected to make important contributions to the Company and by providing such persons with equity ownership opportunities and performance-based incentives that are intended to better align the interests of such persons with those of the Company’s stockholders. Except where the context otherwise requires, the term “Company” shall include any of the Company’s present or future parent or subsidiary corporations as defined in Sections 424(e) or (t) of the Internal Revenue Code of 1986, as amended, and any regulations thereunder (the “Code”) and any other business venture (including, without limitation, joint venture or limited liability company) in which the Com

EX-10.1·8-K·CIK 1501697·ACC 0001501697-26-000047·Filed May 13, 2026, 07:57 EDT

ADVISORY AGREEMENT

This Advisory Agreement (the “Agreement”) is made by and between TransAct Technologies Incorporated, a Delaware corporation with a mailing address of One Hamden Center, 2319 Whitney Avenue, Suite 3B, Hamden, CT 06518 (the “Company”) and Steven A. DeMartino (“you”, “Contractor” or “your”).

1.       The term of this Agreement (the "Term") will be effective as of July 1, 2026, and will continue until December 31, 2026, unless terminated by you or terminated by the Company for Cause as defined in your Employment Agreement..

EX-10.2·8-K·CIK 1017303·ACC 0001214659-26-006001·Filed May 13, 2026, 07:57 EDT

SEPARATION AGREEMENT AND GENERAL RELEASE

This Separation Agreement and General Release (the “Agreement”) confirms the following understandings and agreements between TransAct Technologies Incorporated, a Delaware corporation with a mailing address of One Hamden Center, 2319 Whitney Avenue, Suite 3B, Hamden, CT 06518 (the “Company”) and Steven A. DeMartino (“Executive”) (the Company and Executive are collectively, the “Parties”).

RECITALS

EX-10.1·8-K·CIK 1017303·ACC 0001214659-26-006001·Filed May 13, 2026, 07:57 EDT

EX-10.3

EX-10.3

July 15, 2025

VIA EMAIL ONLY

Dear Susan:

This letter sets forth our agreement (the "Letter Agreement") regarding advisory services to be provided

by you to the Board of Directors of Andersen Group Inc. ("AGI") and your eventual service as a director on the Board of AGI.

1.Effective as of July 16, 2025, you will act as an advisor ("Advisor") to the Board of Directors of AGI, a Delaware corporation until such time as you become a director ("Director") on the Board of AGI which shall occur by no later than July 1, 2026, unless either party provides the other with reasonable advance written notice of termination of your services as an Advisor or Director at any time.

2.Remuneration as follows:

EX-10.3·10-Q·CIK 2065708·ACC 0001193125-26-219544·Filed May 13, 2026, 07:57 EDT

EX-10.1

EX-10.1

FOURTH AMENDED AND RESTATED INVESTMENT ADVISORY

AND MANAGEMENT AGREEMENT

BETWEEN

ARES STRATEGIC INCOME FUND

AND

ARES CAPITAL MANAGEMENT LLC

This Fourth Amended and Restated Investment Advisory and Management Agreement (this “Agreement”), dated as of May 12, 2026 and effective as of June 6, 2026 (the “Effective Date”), is made by and between Ares Strategic Income Fund, a Delaware statutory trust (the “Fund”), and Ares Capital Management LLC, a Delaware limited liability company (the “Adviser”).

WHEREAS, the Fund is a closed-end management investment company that has elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “Investment Company Act”);

WHEREAS, the Adviser is an investment adviser that has registered under the Investment Advisers Act of 1940, as amended (the “Advisers Act”);

EX-10.1·10-Q·CIK 1918712·ACC 0001628280-26-034133·Filed May 13, 2026, 07:57 EDT

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 6, 2026, between Firefly Neuroscience, Inc., a Delaware corporation (the “Company”), and each investor identified on the signature pages hereto (each, including its successors and assigns, an “Investor” and collectively, the “Investors”). Subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”), and/or Rule 506 promulgated thereunder, the Company desires to issue and sell to each Investor, and each Investor, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

THE PARTIES HEREBY AGREE AS FOLLOWS:

1. Purchase and Sale of the Securities.
1.1. Sale and Issuance of the Securities.

EX-10.1·8-K·CIK 803578·ACC 0001213900-26-055110·Filed May 13, 2026, 07:57 EDT

EX-10.2

EX-10.2

Exhibit 10.2

PROMISSORY NOTE

$100,000.00 May 7, 2026
Miami, FL

FOR VALUE RECEIVED, the undersigned, Non-Invasive Monitoring Systems, Inc., a Florida corporation with its principal place of business at 4400 Biscayne Blvd., Miami, FL 33137 (“Maker”), promises to pay to the order of Jane Hsiao of 4400 Biscayne Blvd., 15th Floor Miami, FL 33137 (“Payee”), at such place as may be designated in writing by Payee, the principal sum of ONE HUNDRED THOUSAND AND 00/XX ($100,000.00) (this “Note”).

The principal amount of the loan evidenced hereby, together with any accrued and unpaid interest, and any and all unpaid costs, fees and expenses accrued, shall be due and payable on June 30, 2026 (the “Maturity Date”).

All amounts outstanding from time to time hereunder shall bear interest at the rate of eleven percent (11%) per annum until such amounts are paid.

EX-10.2·8-K·CIK 720762·ACC 0001493152-26-022502·Filed May 13, 2026, 07:57 EDT

EX-10.1

EX-10.1

Exhibit 10.1

PROMISSORY NOTE

$200,000.00 May 7, 2026
Miami, FL

FOR VALUE RECEIVED, the undersigned, Non-Invasive Monitoring Systems, Inc., a Florida corporation with its principal place of business at 4400 Biscayne Blvd., Miami, FL 33137 (“Maker”), promises to pay to the order of Frost Gamma Investments Trust, with its principal place of business at 4400 Biscayne Blvd., 15th Floor Miami, FL 33137 (“Payee”), at such place as may be designated in writing by Payee, the principal sum of TWO HUNDRED THOUSAND AND 00/XX ($200,000.00) (this “Note”).

The principal amount of the loan evidenced hereby, together with any accrued and unpaid interest, and any and all unpaid costs, fees and expenses accrued, shall be due and payable on June 30, 2026 (the “Maturity Date”).

All amounts outstanding from time to time hereunder shall bear interest at the rate of eleven percent (11%) per annum until such amounts are paid.

EX-10.1·8-K·CIK 720762·ACC 0001493152-26-022502·Filed May 13, 2026, 07:57 EDT

ADDENDUM NO. 2 TO SECURITIES PURCHASE AGREEMENT

THIS ADDENDUM NO. 2 (this “Addendum”), dated as of May 10, 2026, to that certain Securities Purchase Agreement (the “Notes SPA”), dated as of June 26, 2025, is entered into by and between Nexera Technologies Ltd (formerly Jeffs’ Brands Ltd), a company incorporated under the law of the State of Israel (the “Company”), and L.I.A. Pure Capital Ltd, a company incorporated under the laws of the State of Israel (the “Buyer”).

Capital terms used but not otherwise defined herein shall have the meanings set forth in the Notes SPA.

WHEREAS, the Company and Buyer have entered into the Notes SPA pursuant to which the Company may issue sell, from time to time, convertible promissory notes (the “Convertible Notes”), in the aggregate principal amount of up to $100,000,000; and

WHEREAS, the parties desire to amend certain terms, effective as of April 1, 2026, as hereinafter set forth.

NOW, THEREFORE, the parties hereby agree as follows:

EX-10.1·6-K·CIK 1885408·ACC 0001213900-26-055116·Filed May 13, 2026, 07:57 EDT

EX-10.2

EX-10.2

1 TCO GROUP HOLDINGS, L.P. EQUITY INCENTIVE PLAN CLASS B UNIT AWARD AGREEMENT THIS AWARD AGREEMENT (this “Agreement”) evidences an award of Class B Units granted pursuant to the TCO Group Holdings, L.P. Equity Incentive Plan (as from time to time amended and in effect, the “Plan”) on May 11, 2026 (the “Grant Date”) and is entered into between TCO Group Holdings, L.P., a Delaware limited partnership (the “Partnership”), and the undersigned Participant (the “Participant”). All capitalized terms that are used but not defined in this Agreement (including Appendix A attached hereto) have the meanings ascribed to them in the Plan. 1. Grant. Subject to the terms and conditions set forth in this Agreement, the Plan and the LP Agreement, the Partnership hereby grants to the Participant on the Grant Date 1,260,000 Class B Units, each with a Hurdle Amount of $7.14 (this “Award”). It is intended that this Award qualify as a “profits interest” for U.S. federal income tax purposes and this Agreement will be interpreted in accordance with that intent. Notwithstanding anything to the contrary in thi

EX-10.2·8-K·CIK 1834376·ACC 0001834376-26-000025·Filed May 13, 2026, 07:57 EDT

EX-10.1

EX-10.1

EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of May 11, 2026 by and between Total Community Options, Inc., d/b/a InnovAge, a Colorado corporation (the “Company”), and Jennifer Browne (the “Executive”), and will become effective on the Executive’s employment start date of June 8, 2026 (the “Effective Date”). RECITALS The Company desires to offer to the Executive employment on the terms and conditions set forth in this Agreement. In consideration of the foregoing premises and the mutual promises, terms, provisions and conditions set forth in this Agreement, the parties hereby agree: 1. Employment. The Executive’s employment shall be subject to the terms and conditions set forth in this Agreement. 2. Term. This Agreement will continue in effect from the Effective Date until terminated in accordance with Section 5 hereof, noting that certain provisions of this Agreement will survive the term of this Agreement as described herein or otherwise pursuant to applicable law. The term of this Agreement is hereafter referred to as “the term of thi

EX-10.1·8-K·CIK 1834376·ACC 0001834376-26-000025·Filed May 13, 2026, 07:57 EDT